Hisense Intelligent Ultrasound Debuts at CMEF, Making High-Quality Diagnostics Accessible
On April 8, the 91st China International Medical Equipment Fair (Spring) (CMEF) officially opened in Shanghai. As a highly influential event in the medical technology industry in the Asia-Pacific region, CMEF is not only a showcase for cutting-edge global medical technology achievements and innovative products but also regarded as the “barometer” of the development of the global medical technology industry.
In the field of ultrasound diagnosis and treatment, Hisense Intelligent Medical made a remarkable debut with its independently developed series of portable, desktop, and intelligent ultrasound products, drawing widespread attention from the industry. Since 2011, Hisense hasUltrasoundSince the establishment of key laboratories and the initiation of preliminary technical research in industrial exploration，Not only has it positioned ultrasound as a core pillar of its strategic layout, but it has also successfully built a product matrix covering full-scenario needs to comprehensively meet the demands of various scenarios.Medicaldemand, and the company is also continuously driving technological innovation to steer ultrasound diagnosis and treatment technologies toward intelligent and precise development, contributing wisdom and strength to the high-quality development of the industry.
Currently, artificial intelligence has become the most prominent phenomenon in the history of human technology. China has included “AI Plus” in its Government Work Report for several consecutive years, with policy implementation evolving steadily. The emphasis has shifted from earlier calls to “accelerate” and “strengthen” to more recent directives to “deepen,” “promote,” and “expand,” culminating in the current initiatives to “launch actions” and “continuously advance.”
This development trend serves as the important backdrop for the current CMEF, themed “Innovative Technology, Leading the Future with Intelligence.” Driven by the wave of “AI+,”Ultrasound, an indispensable tool in modern medical diagnostics, is also undergoing a "two-way" technological revolution.
Compared with standardized imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT), ultrasound is a dynamic, real-time image acquisition technique with a lower degree of procedural standardization. Consequently, ultrasound image quality and diagnostic outcomes are highly dependent on the operator’s real-time performance, making them susceptible to variations in scanning techniques, plane selection, and experience in parameter adjustment. The application of artificial intelligence (AI) is strongly propelling ultrasound medicine toward intelligence, digitalization, and standardization. Meanwhile, ultrasound provides AI with abundant clinical scenarios and data resources, fostering a mutually beneficial relationship between the two.
To clarify the direction of transformation and establish a clear cognitive framework, Hisense Intelligent Medical has taken the lead in the industry by proposing the intelligent “5I” concept (more than Intelligence). This initiative aims to reconstruct medical productivity through technological synergy, enhance the accuracy of imaging diagnosis and physicians’ work efficiency via intelligent methods, and unlock the inclusive value of ultrasound technology.
This concept specifically encompasses Intelligent Detection Indication, Intelligent Quantitative Inspection, Intelligent Operational Instruction, Intelligent Human-Computer Interaction, and Intelligent Image Improvement, driving the dual enhancement of healthcare equity and efficiency across five intelligent dimensions.
To proactively seize the development trends of “AI+”, Hisense Intelligent Medical has also prioritized the innovative applications of large medical models.Through the localized deployment of large medical models, Hisense has achieved breakthrough progress in the intelligentization of imaging equipment.This initiative not only reduces reliance on remote servers and significantly enhances image quality, but also optimizes functional operations and human-computer interaction experiences, making medical imaging equipment more intelligent and user-friendly, thereby bringing about a revolutionary change in clinical diagnosis and treatment.
Furthermore, Hisense Intelligent Healthcare has jointly developed the Hi-Step intelligent diagnostic software with Meinian Onehealth.This software platform adopts an ultra-low-latency architecture, supports the integration of multi-brand devices, and features four core functionalities: real-time consultation, teaching and training, online quality control, and case discussion. This innovative achievement has successfully driven the transformation of medical quality control from the traditional “post-event correction” model to “real-time monitoring,” significantly enhancing the quality and efficiency of healthcare services.
In the highly competitive and rapidly evolving field of ultrasound diagnosis and treatment, Hisense leverages its extensive R&D experience to build a robust technological innovation system. This enables continuous intelligent upgrades of its ultrasound products, significantly enhancing diagnostic efficiency and precision. Meanwhile, to precisely meet diverse clinical needs, the company has established deep collaborations with leading medical institutions in China. By analyzing clinical pain points and practical requirements across different specialties, Hisense has developed a series of ultrasound diagnostic and therapeutic solutions highly tailored to specific specialty needs.
“This dual-wheel-driven development model, combining ‘technological innovation’ with ‘clinical needs,’ is the key to Hisense’s sustained leadership in the ultrasound market.”Su Yutao, Chairman of Hisense Intelligent Healthcaresaid.
At this CMEF, Hisense showcased its series of ultrasound products designed to meet full-scenario needs.From portable ultrasound systems featuring portability, ease of use, and real-time imaging capabilities, to comprehensive desktop ultrasound systems with superior image clarity, to intelligent ultrasound systems integrated with cutting-edge AI technologies, as well as specialized ultrasound systems tailored to the needs of different clinical departments, the practice of these multi-platform product portfolios can comprehensively meet the differentiated market demands from basic to mid-to-high-end segments, providing a referenceable innovation paradigm for the development of the ultrasound industry.
It is worth noting that the 2025 Government Work Report included the “Healthcare Infrastructure Strengthening Project” for the first time. As a key component of this initiative, telemedicine has become a powerful engine driving the healthcare system toward deeper and more balanced development.
In this context, Hisense’s independently developed remote ultrasound platform not only establishes a comprehensive security protection system across physical environments, network communications, device computing, and application data in strict accordance with GB/T 39786-2021 “Basic Requirements for Cryptographic Application of Information Security Technology Information Systems,” but also achieves efficient image synchronization through ultra-low-latency image transmission technology. This enables remote experts to clearly observe patients’ dynamic ultrasound images in real time and conduct precise diagnoses.
Leveraging its technological leadership, the Remote Ultrasound Management Platform System was recognized as an Outstanding Case of Innovative Commercial Cryptography Application in Qingdao in 2024; the project “Key Technologies and Industrialized Applications of Remote Health Services” won the Second Prize of the Beijing Science and Technology Progress Award in 2023.Meanwhile, the company also led the development of China’s first group standard for remote ultrasound, the “Technical Specifications for Remote Ultrasound Diagnostic Information Systems,” driving the industry to make significant strides toward standardization and normalization.
2025 is regarded as the inaugural year of the AI application boom. Leveraging the dual advantages of AI and precision imaging technology, Hisense Intelligent Medical Care is driven by innovation to revolutionize smart healthcare service models across multiple dimensions, thereby benefiting more hospitals and patients—First, optimize AI-assisted diagnostic capabilities by expanding the range of intelligently identifiable conditions, thereby enhancing diagnostic accuracy and efficiency while alleviating physicians’ workload. Second, create a user experience aligned with clinicians’ workflows by adding more examination sites and simplifying operational processes to enable primary-care physicians to adopt the system with ease. Third, intensify marketing efforts in the primary healthcare sector to increase ultrasound equipment coverage, promote the adoption of remote ultrasound solutions, and foster balanced distribution of medical resources.
It is precisely through these innovative initiatives and solid market positioning that Hisense Intelligent Healthcare has continuously enhanced its influence. Relevant survey data show that in 2024, the installation volume of Hisense ultrasound products in primary-care hospitals in certain regions ranked first in the market. Furthermore, in March 2025, at the 15th China Healthcare Industry Data Conference and Medical Technology Innovation Conference, Hisense was honored with the “2024 China Excellent Domestic Brand Award for Medical Equipment” in recognition of its technological breakthroughs in intelligent ultrasound.
Su Yutao stated, “These achievements not only signify recognition of Hisense Ultrasound in technological innovation and the market, but also mark a transition for domestically produced medical imaging equipment from ‘import substitution’ to ‘market leadership,’ driven by both policy support and technological breakthroughs.”
It is foreseeable that, with the continued deepening of the “AI+” strategy, ultrasound equipment will accelerate its evolution toward intelligence and widespread adoption, playing an increasingly significant role in telemedicine, chronic disease management, and other fields. As a representative enterprise in the field of intelligent ultrasound, Hisense will gain deep insights into clinical needs and develop comprehensive, scenario-based smart healthcare solutions. Meanwhile, adhering to its quality policy of “precision medicine, safety and reliability, continuous innovation, and compliance first,” the company will establish a quality control system spanning the entire product lifecycle. Committed to creating the most user-friendly medical diagnostic products in the industry, Hisense aims to enable more healthcare institutions and physicians to access high-quality intelligent devices, promote the balanced distribution of medical resources, and contribute to the advancement of global human health.